Louise Crowe1, Alex Collie2, Stephen Hearps3, Julian Dooley1, Helen Clausen4, David Maddocks5, Paul McCrory6, Gavin Davis7, Vicki Anderson1. 1. Child Neuropsychology, Murdoch Children's Research Institute, Melbourne, Australia. 2. Institute for Safety Compensation and Recovery Research, Monash University, Melbourne, Australia. 3. Centre for Adolescent Health, Murdoch Children's Research Institute, Melbourne, Australia. 4. Melbourne Neuropsychology Services, Melbourne, Australia. 5. Perry Maddocks Trellope, Lawyers, Melbourne, Australia. 6. The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia. 7. Neurosurgery Department, Cabrini Hospital, Melbourne, Australia.
Abstract
BACKGROUND: Recovery from concussion sustained in childhood and adolescence is poorly understood. We explored patterns of recovery for neurocognition and postconcussive symptoms following concussion in children and adolescents. METHODS: Using a prospective, longitudinal design, we collected baseline data on 728 children and adolescents aged 10-17 years. 10 participants sustained a concussive injury (n=10) in the 12 months following baseline testing and they were reviewed at day 5, 10 and 30 postconcussion. Assessments included the CogSport for Kids computerised test battery to evaluate neurocognitive function and self-report, and parent measures of postconcussive symptoms. At day 30, parents also completed measures rating their child's quality of life and executive functions. RESULTS: Children and adolescents displayed a gradual reduction in postconcussive symptoms over the 30 days following injury. At day 5, 87% of participants were reporting physical and cognitive symptoms, with a generalised reduction in all symptoms by day 10 (40% of participants). On the computerised measure, reaction time was slower after concussion, but returned to baseline levels by day 30. At day 30, 10% of participants demonstrated ongoing postconcussive symptoms. Number of previous concussions was related to speed of symptom resolution. CONCLUSIONS: At 5 days postconcussion, the majority of children and adolescents experienced debilitating postconcussive symptoms. However, by 30 days postinjury, 90% demonstrated recovery to normal for both neurocognition and postconcussive symptoms. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Recovery from concussion sustained in childhood and adolescence is poorly understood. We explored patterns of recovery for neurocognition and postconcussive symptoms following concussion in children and adolescents. METHODS: Using a prospective, longitudinal design, we collected baseline data on 728 children and adolescents aged 10-17 years. 10 participants sustained a concussive injury (n=10) in the 12 months following baseline testing and they were reviewed at day 5, 10 and 30 postconcussion. Assessments included the CogSport for Kids computerised test battery to evaluate neurocognitive function and self-report, and parent measures of postconcussive symptoms. At day 30, parents also completed measures rating their child's quality of life and executive functions. RESULTS:Children and adolescents displayed a gradual reduction in postconcussive symptoms over the 30 days following injury. At day 5, 87% of participants were reporting physical and cognitive symptoms, with a generalised reduction in all symptoms by day 10 (40% of participants). On the computerised measure, reaction time was slower after concussion, but returned to baseline levels by day 30. At day 30, 10% of participants demonstrated ongoing postconcussive symptoms. Number of previous concussions was related to speed of symptom resolution. CONCLUSIONS: At 5 days postconcussion, the majority of children and adolescents experienced debilitating postconcussive symptoms. However, by 30 days postinjury, 90% demonstrated recovery to normal for both neurocognition and postconcussive symptoms. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Juliet Haarbauer-Krupa; Tadesse Haileyesus; Julie Gilchrist; Karin A Mack; Caitlin S Law; Andrew Joseph Journal: J Safety Res Date: 2019-06-21
Authors: Mohammad Nadir Haider; John J Leddy; Sonja Pavlesen; Melissa Kluczynski; John G Baker; Jeffrey C Miecznikowski; Barry S Willer Journal: Br J Sports Med Date: 2017-07-22 Impact factor: 13.800
Authors: Frederick Robert Carrick; Joseph F Clark; Guido Pagnacco; Matthew M Antonucci; Ahmed Hankir; Rashid Zaman; Elena Oggero Journal: Front Neurol Date: 2017-08-22 Impact factor: 4.003
Authors: João Paulo Lima Santos; Anthony P Kontos; Sarrah Mailliard; Shawn R Eagle; Cynthia L Holland; Stephen J Suss; Halimah Abdul-Waalee; Richelle S Stiffler; Hannah B Bitzer; Nicholas A Blaney; Adam T Colorito; Christopher G Santucci; Allison Brown; Tae Kim; Satish Iyengar; Alexander Skeba; Rasim S Diler; Cecile D Ladouceur; Mary L Phillips; David Brent; Michael W Collins; Amelia Versace Journal: Front Neurol Date: 2021-06-24 Impact factor: 4.003